Abstract:Cytotoxic T lymphocytes and NK cells play an important role in eliminating malignant tumor cells and the number and activity of tumor-infiltrating T cells represent a good marker for tumor prognosis. Based on these findings, immunotherapy, e.g., checkpoint blockade, has received considerable attention during the last couple of years. However, for the majority of patients, immune control of their tumors is gray theory as malignant cells use effective mechanisms to outsmart the immune system. Increasing evidence suggests that changes in tumor metabolism not only ensure an effective energy supply and generation of building blocks for tumor growth but also contribute to inhibition of the antitumor response. Immunosuppression in the tumor microenvironment is often based on the mutual metabolic requirements of immune cells and tumor cells. Cytotoxic T and NK cell activation leads to an increased demand for glucose and amino acids, a well-known feature shown by tumor cells. These close metabolic interdependencies result in metabolic competition, limiting the proliferation, and effector functions of tumor-specific immune cells. Moreover, not only nutrient restriction but also tumor-driven shifts in metabolite abundance and accumulation of metabolic waste products (e.g., lactate) lead to local immunosuppression, thereby facilitating tumor progression and metastasis. In this review, we describe the metabolic interplay between immune cells and tumor cells and discuss tumor cell metabolism as a target structure for cancer therapy. Metabolic (re)education of tumor cells is not only an approach to kill tumor cells directly but could overcome metabolic immunosuppression in the tumor microenvironment and thereby facilitate immunotherapy.

NK Cell Metabolism and Tumor Microenvironment

The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity

Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment

The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity

Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment

Metabolic hallmarks of natural killer cells in the tumor microenvironment and implications in cancer immunotherapy

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells

Shaping of NK Cell Responses by the Tumor Microenvironment

Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy

Targeting Natural Killer Cells for Tumor Immunotherapy

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Targeting metabolism to enhance immunotherapy within tumor microenvironment

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy

Natural killer cells in cancer biology and therapy

Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer

Immunometabolism and natural killer cell responses

Lipid Metabolism in Tumor-Associated Natural Killer Cells.

Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function

Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies